Warning Issued Over Hair Loss and Prostate Drug Finasteride

Published on May 1, 2024

A patient alert system was announced on Monday by the medical regulator to monitor men taking the drug finasteride, which can cause serious psychiatric problems and interfere with normal sexual function even after the medication has been stopped. The Medicines and Healthcare products Regulatory Agency (MHRA) has no plans to withdraw the drug and is instead urging men to “stay vigilant” for side effects following its review into the safety of finasteride—used by the NHS to treat an enlarged prostate and often prescribed privately to combat male pattern baldness. Propecia, the brand name for the version of finasteride used to treat hair loss, and Proscare, used to treat enlarged prostate, are manufactured by Organon, a spinoff from the pharma giant Merck & Co. Other companies have been making a generic version of finasteride since 2014, when the patent for Propecia expired....